Malabsorci車n de lactosa en pacientes con enfermedad inflamatoria intestinal inactiva: ˋest芍 justificado excluir los productos l芍cteos a todos los pacientes?

作者：Baos Madrid; R; Salama Benarroch; H; Moran Sanchez; S; Gallardo Sanchez; F; Albaladejo Meroo; A; Mercader Martinez; J

来源：Anales de Medicina Interna, 2004.

DOI：10.4321/S0212-71992004000500002

• inflammatory bowel disease
• lactose malabsorption
• breath testing.

introduction: there are inflammatory bowel disease (ibd) patients avoid lactealproducts withoutevidenceof lactose malabsorption, probablybecause of incorrect patient perceptions and arbitrary advice from physicians anddiet books. aim: to evaluate the prevalence of lactose malabsorption in patients with ibp. method: in 18 patients with crohn%26apos;s diseaseand24 with ulcerative colitis and25 controls the prevalence of lactose intolerance, as measured by lactose breath hydrogen tests. results: observed deficiencies of absorption of the lactose in 7 (16.6%) patients with ibpand 5 (20%) subjects control. conclusions: not all the patients with ibd are intolerant to the lactose by the suppression of the lacteal produts must not be generalized in the diet of these patients.